IRCT20120215009014N488
Not yet recruiting
Phase 3
Effect of Botulinum A toxin versus anticholinergic on clinical symptoms of patients with overactive bladder: a randomized clinical trial
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Hamedan University of Medical Sciences
- Enrollment
- 42
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age 18 to 80 years
- •Overactive bladder
Exclusion Criteria
- •Pregnancy or breastfeeding
- •Neuromuscular diseases
- •Taking anticoagulants
- •Allergy to egg white
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 3
Efficacy of MASPORT in BlepharospasmBenign Essential Blepharospasm (BEB).BlepharospasmG24.5IRCT20240216061023N1Shahid Beheshti University of Medical Sciences19
Completed
Not Applicable
comparison of the effect of botulinium toxin A injection with placebo in reducing the pain of patients with myofacial paitemporomandibular disorder.Temporomandibular joint disordersIRCT2016051527894N2Vice chancellor for research of Ahvaz Jundishapur University of Medical Sciences34
Not yet recruiting
Phase 3
Effect of Botulinum Toxin Type A on neuromuscular adaptations in individuals with muscle stiffness after StrokeRBR-7s8qnjjniversidade Federal do Rio Grande do Sul -UFRGS
Not yet recruiting
Phase 3
medical versus surgical treatment in idiopathic clubfoot patientsCTRI/2021/01/030466AIIMS RAIPUR
Recruiting
Phase 3
Evaluation the effect of Botulinium toxin injection on improving symptoms in patients with diabetic neuropathyIRCT20240116060710N1Shahid Beheshti University of Medical Sciences30